tradingkey.logo

Electromed Inc

ELMD
查看詳細走勢圖
29.110USD
+0.110+0.38%
收盤 02/06, 16:00美東報價延遲15分鐘
243.27M總市值
29.82本益比TTM

Electromed Inc

29.110
+0.110+0.38%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+0.38%

5天

-2.54%

1月

+2.54%

6月

+57.95%

今年開始到現在

-0.03%

1年

-15.13%

查看詳細走勢圖

TradingKey Electromed Inc股票評分

單位: USD 更新時間: 2026-02-06

操作建議

Electromed Inc當前公司基本面數據相對非常健康,最新ESG揭露屬於行業領先水平。增長潛力很大。當前估值合理,在醫療設備與耗材行業排名59/205位。機構持股佔比非常高,近一月多位分析師給出公司評級為買入。最高目標價為36.00。中期看,股價處於上升通道。近一個月,市場表現一般,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Electromed Inc評分

相關信息

行業排名
59 / 205
全市場排名
165 / 4521
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
中性

Electromed Inc亮點

亮點風險
Electromed, Inc. develops, manufactures, markets and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System, to patients with compromised pulmonary function. It applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The SmartVest Clearway System consists of an inflatable therapy garment, a programmable air pulse generator and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall. The SmartVest Clearway is designed for comfort and convenience, so patients can readily fit therapy into their daily routines. The SmartVest System is primarily prescribed for patients with bronchiectasis, cystic fibrosis, and neuromuscular conditions such as cerebral palsy and amyotrophic lateral sclerosis. It also markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to health care providers in the acute care setting.
業績高增長
公司營業收入穩步增長,連續3年增長33.15%
業績增長期
公司處於發展階段,最新年度總收入64.00M美元
利潤高增長
公司淨利潤處於行業前列,最新年度總收入64.00M美元
估值合理
公司最新PE估值29.82,處於3年歷史合理位
機構減倉
最新機構持股4.36M股,環比減少0.04%
先鋒集團持倉
明星投資者先鋒集團持倉,最新持倉447.28K股

分析師目標

基於 4 分析師
買入
評級
36.000
目標均價
+24.14%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Electromed Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Electromed Inc簡介

Electromed, Inc. develops, manufactures, markets and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System, to patients with compromised pulmonary function. It applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The SmartVest Clearway System consists of an inflatable therapy garment, a programmable air pulse generator and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall. The SmartVest Clearway is designed for comfort and convenience, so patients can readily fit therapy into their daily routines. The SmartVest System is primarily prescribed for patients with bronchiectasis, cystic fibrosis, and neuromuscular conditions such as cerebral palsy and amyotrophic lateral sclerosis. It also markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to health care providers in the acute care setting.
公司代碼ELMD
公司Electromed Inc
CEOCunniff (James L)
網址https://smartvest.com/
KeyAI